Moneycontrol
Jul 22, 2013 03:48 PM IST | Source: Moneycontrol.com

Lupin receives FDA approval for Generic GIumetza extended-release tablets

Lupin’s US subsidiary, Lupin Pharmaceuticals, Inc (LPI) has received final approval for its Metformin Hydrochloride extended release tablets 500 mg and 1000 mg from United States Food and Drugs Administration.

Lupin receives FDA approval for Generic GIumetza extended-release tablets

Lupin Ltd has informed BSE regarding a Press Release dated July 22, 2013, titled "Lupin receives FDA approval for Generic GIumetza extended-release Tablets"

Lupin
Sections
Follow us on
Available On